Margetuximab (Anti-ERBB2 / HER2 / CD340)

Margetuximab (Anti-ERBB2 / HER2 / CD340) is a Fc-domain optimized IgG monoclonal antibody directed against the human epidermal growth factor receptor 2 (HER2) with potential immunomodulating and antineoplastic activities. MW: 146.1 KD.

Margetuximab (Anti-ERBB2 / HER2 / CD340)

Purity & Quality Control

Batch: A289901 Purity: 99% Protein concentration: 7.96mg/ml Endotoxin Level: <1EU/mg
99

Choose Selective HER2 Inhibitors

Biological Activity

Description Margetuximab (Anti-ERBB2 / HER2 / CD340) is a Fc-domain optimized IgG monoclonal antibody directed against the human epidermal growth factor receptor 2 (HER2) with potential immunomodulating and antineoplastic activities. MW: 146.1 KD.

Product Details

CAS No. 1350624-75-7
Molecular Weight 146.1
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Margetuximab (Anti-ERBB2 / HER2 / CD340) | Margetuximab (Anti-ERBB2 / HER2 / CD340) supplier | purchase Margetuximab (Anti-ERBB2 / HER2 / CD340) | Margetuximab (Anti-ERBB2 / HER2 / CD340) cost | Margetuximab (Anti-ERBB2 / HER2 / CD340) manufacturer | order Margetuximab (Anti-ERBB2 / HER2 / CD340) | Margetuximab (Anti-ERBB2 / HER2 / CD340) distributor